Honz Pharmaceutical Co., Ltd. (SHE:300086)

China · Delayed Price · Currency is CNY

6.94

-0.25 (-3.48%)

May 21, 2026, 3:04 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceutical Manufacturing and Sales Division		426.23M	-	455.16M	573.81M	547.00M
Pharmaceutical Manufacturing and Sales Division Growth		-	-	-20.68%	4.90%	-5.31%
Production and Sales of Daily Necessities		49.45M	-	80.58M	99.45M	110.17M
Production and Sales of Daily Necessities Growth		-	-	-18.97%	-9.73%	-27.25%
Inter-Segment Elimination		-2.87M	-	-	-	-
Medical Services Division		-	-	-	163.31M	264.47M
Medical Services Division Growth		-	-	-	-38.25%	-5.32%
Total		472.82M	-	535.75M	836.57M	921.64M
Total Growth		-	-	-35.96%	-9.23%	-8.61%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China		471.07M	738.44M	535.55M	835.94M	918.21M
China Growth		-36.21%	37.88%	-35.93%	-8.96%	-8.41%
Foreign		1.74M	1.13M	190.87K	628.05K	3.43M
Foreign Growth		54.28%	491.85%	-69.61%	-81.70%	-41.38%
Total		472.82M	739.57M	535.75M	836.57M	921.64M
Total Growth		-36.07%	38.05%	-35.96%	-9.23%	-8.61%

Source: S&P Global Market Intelligence.